City

Clinical trials near Edmonton, Canada

Active studies with a listed research site in Edmonton, Canada.

13active studies

7recruiting now

18countries represented

256largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Crohn's Disease, Obesity or OverweightCondition

Mirikizumab, MirikizumabTreatment

Austria, Belgium183 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06937099See eligibility →

Recruiting nowNot applicable

Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass

Type 2 Diabetes, ObesityCondition

Intervention not listedTreatment

Canada1 locations

University of AlbertaSponsor

Updated 2026-07-17 · NCT07272837See eligibility →

Recruiting nowNot applicable

Metabolic and Inflammatory Outcomes of the Ketogenic Diet Comparing Saturated and Unsaturated Fat Sources

PreDiabetes, Diabetes Mellitus, Type 2Condition

Keto-SAT, Keto-CANTreatment

Canada1 locations

University of AlbertaSponsor

Updated 2026-07-16 · NCT05681468See eligibility →

Recruiting nowNot applicable

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

Chronic Kidney Disease in Type 2 Diabetes, Obesity & OverweightCondition

Intervention not listedTreatment

Canada1 locations

University of AlbertaSponsor

Updated 2026-05-11 · NCT07187830See eligibility →

Recruiting nowPhase 2

Transpulmonary Assessment for Individualized Lung Optimization in Obese Patients

Respiratory FailureCondition

Esophageal pressure-guided PEEP titration, Standard care PEEP managementTreatment

Canada2 locations

University of AlbertaSponsor

Updated 2026-04-13 · NCT07359261See eligibility →

Recruiting nowPhase 1

Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study

High Blood Sugar, High Blood PressureCondition

Egg White PowderTreatment

Canada1 locations

University of AlbertaSponsor

Updated 2026-03-13 · NCT06555393See eligibility →

Recruiting nowPhase 3

Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance

Obesity, Childhood, Insulin ResistanceCondition

Metformin 850 mg oral tablet bid, Supplemental fiber mixture (35 g total) composed of 6g of Oligofructose + 12g of resistant maltodextrin + 12g of acacia gum + 5g of PGX.Treatment

Canada1 locations

University of AlbertaSponsor

Updated 2025-11-17 · NCT04578652See eligibility →

Active, not recruitingPhase 3

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

ObesityCondition

Cagrilintide, SemaglutideTreatment

Argentina, Australia256 locations

Novo Nordisk A/SSponsor

Updated 2026-08-31 · NCT05567796See eligibility →

Active, not recruitingPhase 3

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

Diabetes Mellitus, Type 2Condition

Semaglutide, Placebo (semaglutide)Treatment

Brazil, Bulgaria229 locations

Novo Nordisk A/SSponsor

Updated 2026-08-04 · NCT03811561See eligibility →

Active, not recruitingPhase 3

A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Obesity, OverweightCondition

Tirzepatide, PlaceboTreatment

Canada, Czechia33 locations

Eli Lilly and CompanySponsor

Updated 2026-06-29 · NCT06075667See eligibility →

Active, not recruitingPhase 4

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

ObesityCondition

SemaglutideTreatment

Belgium, Canada93 locations

Novo Nordisk A/SSponsor

Updated 2026-06-02 · NCT06571383See eligibility →

Active, not recruitingPhase 3

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

Diabetes Mellitus, Type 2Condition

Retatrutide, SemaglutideTreatment

Argentina, Canada77 locations

Eli Lilly and CompanySponsor

Updated 2026-04-13 · NCT06260722See eligibility →

Active, not recruitingNot applicable

Attrition in Pediatric Obesity Management

Child ObesityCondition

Family Navigation, Usual CareTreatment

Canada1 locations

University of AlbertaSponsor

Updated 2026-01-08 · NCT05403658See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Edmonton, Canada

Current studies

Related cities